1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
64B385F33CAFC210985257B28006816C2
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/grow-franchise-top-line-improve-sales-corporate-reputation?opendocument
18
19opendocument
2044.220.247.152
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Brand Management and Product Leadership » Product Marketing and Innovation

Using a Franchise Approach to Support Multiple Products: Enhancing Sales Force Effectiveness and Corporate Reputation

ID: 5242


Features:

12 Info Graphics

19 Data Graphics

260+ Metrics

5 Narratives

1 Best Practices


Pages/Slides: 40


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Using a Franchise Approach to Support Multiple Products: Enhancing Sales Force Effectiveness and Corporate Reputation"

STUDY OVERVIEW
Launching and growing multiple products is both resource-intensive and strategically challenging. Two ways in which franchise managers can maximize the value of their portfolio are driving revenue growth across products and reaping the reputational rewards of therapeutic area leadership.

This Best Practices, LLC study delivers performance benchmarks on how companies efficiently manage multiple similar products and indications to best leverage precious resources. The research captures best practices for growing the franchise top-line through managing sales alignment, territories, and SFE metrics. In addition, the study also identifies how to enhance corporate reputation by employing efficient digital marketing technologies (for recently launched products) and applying other innovative promotional approaches to support integrated product portfolios or franchises.

Franchise managers can use this study to evaluate and improve the management of their pipelines and to inform strategic management decisions of these portfolio assets.


KEY TOPICS

  • Universe of Learning: Key Demographics of Participating Companies
  • Growing the Top-Line
  • Enhancing Corporate Reputation
  • Critical Franchise Risk Points

SAMPLE KEY METRICS
  • Successful Franchise Benefits as a Result of Managing Similar Products as Part of an Integrated Product Franchise
  • Effectiveness of Combining and Leveraging Resources for Efficient Customer Targeting When Promoting Multiple Similar Products in the Same Therapeutic Area
  • Best Approaches for Reducing Internal Competition Among Sales Representatives Working in Common Hospitals or Territories
  • Change in Sales Territory Alignment as a Result of an Integrated Approach to Portfolio or Franchise Promotion
  • Effectiveness of Combining Resources for the SFE Tactics When Promoting Multiple Similar Products in the Same Therapeutic Area
  • Aligning Reps Inside the Franchise Through Incentives
  • Sales Territory Alignment to Maximize Efficiency
  • Effectiveness of Sales Performance Metrics Within an Integrated Product Portfolio or Franchise
  • Top Lessons Learned for Efficiently Launching & Promoting Multiple Similar Products
  • Role Different Groups Play in Managing an Integrated Product Portfolio
  • Effectiveness of Combining and Leveraging Resources for Digital Marketing Services to Promote Multiple Indications / Products in the Same Therapeutic Area
  • Effectiveness of Combining and Leveraging Resources for Different Managed Markets Services to Promote Multiple Indications / Products in the Same Therapeutic Area
  • Critical Franchise Management Pitfalls When Leveraging Resources to Serve an Integrated Product Franchise
  • Product franchise type/profile
  • Risk Assessment of Stumbling or Mishandling Multiple Launches (New Products or New Indications) When They Occur In Short Proximity Within the Same Sales Force
SAMPLE KEY FINDING
  • Keep Sales Territories Smaller During Launch Phase - and Consider Shrinking Rep-to-Customer Ratio: A majority of benchmark franchises (55%) find it highly effective to keep territory size small during important product lifecycle phases such as launch. Similarly, 45% of companies also manage resources efficiently by reducing the customer target numbers for reps during peak lifecycle phases.
METHODOLOGY

Best Practices, LLC engaged 65 Sales, Marketing, and Commercial leaders from 52 leading healthcare companies through a benchmarking survey instrument to collect quantitative data and qualitative insights.

Industries Profiled:
Consumer Products; Diagnostic; Pharmaceutical; Medical Device; Biopharmaceutical; Health Care; Biotech; Market Research; Utilities; Chemical; Clinical Research; Laboratories


Companies Profiled:
Bayer Healthcare; Shionogi Inc.; Roche Diagnostics; Mylan; GlaxoSmithKline ; Drager; CareFusion; B.Braun; Astellas; Entelos; Alcon; Siren Interactive; AstraZeneca; Nonin; Menarini Group; Hikma; Novartis; Nico ; Lupin; Centurion; Covidien; Galpha Laboratories; Catalent Pharma Solutions; Genentech; Almirall; Abbott; Sandoz; Johnson & Johnson; Dr Reddy's Laboratories; Merck; Meda Pharmaceuticals; Sanofi; Amylin; Teva Pharmaceutical Industries Ltd; Glenmark; Boehringer Ingelheim; Wockhardt; Novo Nordisk; Ranbaxy; Daiichi Pharmaceutical Co.; Ltd.; Roche; Baxter Healthcare; Medtronic; Shire; UCB Pharma; Stryker; Gilead Sciences; Biogen Idec; Boston Scientific; Zydus Cadila; Janssen; cipla

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.